Titel

Merkliste
1 Ergebnisse

Kaplan–Meier curves for the time to the first chronic pulmo..:

Elena L. Amelina (9628831) ; Stanislav A. Krasovsky (11873571) ; Nina E. Akhtyamova-Givirovskaya (11873574)...
https://figshare.com/articles/figure/Kaplan_Meier_curves_for_the_time_to_the_first_chronic_pulmonary_disease_exacerbation_FAS_and_PP_populations_/17431578. , 2021

Link: https://doi.org/10.1371/journal.pone.0261410.g002

RT Journal
T1 <Title>Kaplan–Meier curves for the time to the first chronic pulmonary disease exacerbation (FAS and PP populations)</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_17431578&Exemplar=1&LAN=DE
				
A1 Elena L. Amelina (9628831)
A1 Stanislav A. Krasovsky (11873571)
A1 Nina E. Akhtyamova-Givirovskaya (11873574)
A1 Nataliya Yu. Kashirskaya (11873577)
A1 Diana I. Abdulganieva (11873580)
A1 Irina K. Asherova (11873583)
A1 Ilya E. Zilber (11873586)
A1 Liliya S. Kozyreva (11873589)
A1 Lubov M. Kudelya (11873592)
A1 Natalya D. Ponomareva (11873595)
A1 Nataliya P. Revel-Muroz (11873598)
A1 Elena M. Reutskaya (11873601)
A1 Tatiana A. Stepanenko (11873604)
A1 Gulnara N. Seitova (11873607)
A1 Olga P. Ukhanova (11873610)
A1 Olga V. Magnitskaya (11873613)
A1 Dmitry A. Kudlay (11873616)
A1 Oksana A. Markova (11873619)
A1 Elena V. Gapchenko (11873622)
YR 2021
K1 Biochemistry
K1 Medicine
K1 Microbiology
K1 Cell Biology
K1 Genetics
K1 Biotechnology
K1 Immunology
K1 Cancer
K1 Mental Health
K1 Infectious Diseases
K1 Virology
K1 mean fvc changes
K1 george &# 8217
K1 expensive medicinal products
K1 compared efficacy endpoints
K1 term symptomatic therapy
K1 label clinical trial
K1 analyses included subgroup
K1 larger comparative study
K1 patients ' data
K1 100 patients registered
K1 secondary efficacy parameters
K1 similar mean fev
K1 severe pulmonary impairment
K1 nct04468100 ))</ p
K1 severe impairment
K1 efficacy dataset
K1 adequate therapy
K1 study support
K1 randomized study
K1 nct04468100 )
K1 nct04468100 ))
K1 23 patients
K1 clinical tigerase
K1 treatment group
K1 subgroup analysis
K1 safety parameters
K1 respiratory questionnaire
K1 generic version
K1 first biosimilar
K1 drug antibody
K1 dornase alfa
K1 cystic fibrosis
K1 comparable drug
K1 comparable among
K1 body weight
K1 baseline fev
K1 also comparable
K1 24 weeks
JF https://figshare.com/articles/figure/Kaplan_Meier_curves_for_the_time_to_the_first_chronic_pulmonary_disease_exacerbation_FAS_and_PP_populations_/17431578
LK http://dx.doi.org/https://doi.org/10.1371/journal.pone.0261410.g002
DO https://doi.org/10.1371/journal.pone.0261410.g002
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)